Computing care

How Tempus is using machine learning to help docs choose cancer treatments

Tempus Labs Inc. has created a machine learning tool that can help physicians make better treatment decisions by comparing a cancer patient’s genetic and clinical profile to those of thousands of other patients with known treatment outcomes.

The tool supplements molecular profiling conducted in the company’s CLIA lab by placing the results in the context of a vast set of data -- including genetic information, pathology reports, physician notes and treatment outcomes -- that are otherwise unavailable to

Read the full 772 word article

User Sign In